MacroGenics, Inc. (MGNX) NASDAQ

1.62

+0.02(+1.25%)

Updated at December 24 01:00PM

Currency In USD

Valuation

Market Cap203.52M
Enterprise Value58.14M
P/E Ratio-1.35
PEG Ratio0.01
Price/Sales Ratio0.81
Price/Book Ratio1.53
Enterprise/Revenue0.47
Enterprise/EBITDA-0.94

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.6
Operating Margin-0.9

Management Effectiveness

Return On Assets-0.28
Return On Equity-0.98

Income Statement

Revenue148.34M
Revenue/Share1.99
Gross Profit136.04M
EBITDA-57.37M
Net Income-66.97M
Diluted EPS-1.07

Balance Sheet

Total Cash146.4M
Total Cash/Share2.32
Total Debt37.01M
Total Debt/Equity0.55
Current Ratio5.22
Book Value Per Share1.06

Price History

52-Week Change-50.31
52-Week High3.6
52-Week Low0.99
Moving Average 50 Days1.54
Moving Average 200 Days1.58

Statistics

Average Volume1.26M
Shares Outstanding63.26M
% Held by Institutions72.85

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A